| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Nandini Devi last filed a Form 4 in June 2023, as Director at IRIX. Nandini Devi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Nandini Devi a below-average insider score of 19/100, based on 3 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -49.6%.
At the last filing, the largest reported position was 77,159 shares of IRIX. Net of sales, the IRIX filings show accumulation of 5,000 shares.
Nandini Devi has 6 Form 4 filings on record from June 2021 to June 2023, all as Director at Iridex (IRIX), 2021–2023.
The 7 reported transactions were 3 stock awards, 3 open-market purchases and 1 option or other derivative award.
Counted by filing, the open-market trades come to 3 purchases worth about $22K and no sales.
The largest open-market purchase was 2,000 shares of IRIX at an average $4.20 on March 16, 2022, about $8K. Twelve months later IRIX was down 51%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.